Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 238

1.

Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline.

Crugnola M, Castagnetti F, Breccia M, Ferrero D, Trawinska MM, Abruzzese E, Annunziata M, Stagno F, Tiribelli M, Binotto G, Bonifacio M, Fava C, Iurlo A, Bucelli C, Mansueto G, Gozzini A, Falzetti F, Montefusco E, Crisà E, Gugliotta G, Russo S, Cedrone M, RussoRossi A, Pregno P, Isidori A, Mauro E, Atelda R, Giglio G, Celesti F, Sorà F, Storti S, D'Addosio A, Galimberti S, Orlandi E, Calistri E, Bocchia M, Cavazzini F, Rege Cambrin G, Orofino N, Luciano L, Sgherza N, Rosti G, Latagliata R, Capodanno I.

Ann Hematol. 2019 Aug 7. doi: 10.1007/s00277-019-03767-y. [Epub ahead of print]

PMID:
31392461
2.

'Secondary chronic myeloid leukemia': comparison between patients previously exposed or not to chemo- and/or radiotherapy.

Autore F, Sorà F, Chiusolo P, Annunziata M, Iurlo A, Cattaneo D, Galimberti S, Bajer JA, Sica S.

Leuk Lymphoma. 2019 Jul 11:1-3. doi: 10.1080/10428194.2019.1639162. [Epub ahead of print] No abstract available.

PMID:
31294653
3.

Current Recommendations and Novel Strategies for the Management of Skin Toxicities Related to Anti-EGFR Therapies in Patients with Metastatic Colorectal Cancer.

Annunziata MC, De Stefano A, Fabbrocini G, Leo S, Marchetti P, Romano MC, Romano I.

Clin Drug Investig. 2019 Jul 1. doi: 10.1007/s40261-019-00811-7. [Epub ahead of print] Review.

PMID:
31264159
4.

What Is Lignin Made of? New Components Discovered!

Annunziata MG.

Plant Physiol. 2019 Jul;180(3):1255. doi: 10.1104/pp.19.00561. No abstract available.

5.

Treatment Outcomes of Immune-Related Cutaneous Adverse Events.

Phillips GS, Wu J, Hellmann MD, Postow MA, Rizvi NA, Freites-Martinez A, Chan D, Dusza S, Motzer RJ, Rosenberg JE, Callahan MK, Chapman PB, Geskin L, Lopez AT, Reed VA, Fabbrocini G, Annunziata MC, Kukoyi O, Pabani A, Yang CH, Chung WH, Markova A, Lacouture ME.

J Clin Oncol. 2019 Jun 19:JCO1802141. doi: 10.1200/JCO.18.02141. [Epub ahead of print]

PMID:
31216228
6.

Plant Leaf Apoplast: An Easy Method to Estimate Its Hydration State and Contents.

Annunziata MG.

Plant Physiol. 2019 Jun;180(2):688. doi: 10.1104/pp.19.00312. No abstract available.

PMID:
31160519
7.

Adalimumab versus Rifampicin Plus Clindamycin for the Treatment of Moderate to Severe Hidradenitis Suppurativa: A Retrospective Study

Marasca C, Annunziata MC, Villani A, Volpe S, Marasca D, Fabbrocini G.

J Drugs Dermatol. 2019 May 1;18(5):437-438.

PMID:
31141853
8.

Incidence and evaluation of predisposition to cardiovascular toxicity in chronic myeloid leukemia patients treated with bosutinib in the real-life practice.

Caocci G, Mulas O, Abruzzese E, Iurlo A, Annunziata M, Orlandi EM, Galimberti S, Binotto G, Sgherza N, Luciano L, Martino B, Russo Rossi A, Bonifacio M, Fozza C, Trawinska MM, Cattaneo D, Elena C, Baratè C, De Gregorio F, Molica M, La Nasa G, Foà R, Breccia M.

Ann Hematol. 2019 Aug;98(8):1885-1890. doi: 10.1007/s00277-019-03705-y. Epub 2019 May 1.

PMID:
31044260
9.

Recurrent arterial occlusive events in patients with chronic myeloid leukemia treated with second- and third-generation tyrosine kinase inhibitors and role of secondary prevention.

Caocci G, Mulas O, Bonifacio M, Abruzzese E, Galimberti S, Orlandi EM, Iurlo A, Annunziata M, Luciano L, Castagnetti F, Gozzini A, Stagno F, Binotto G, Pregno P, Albano F, Martino B, Fozza C, Scaffidi L, Trawinska MM, Baratè C, Elena C, Cattaneo D, Scalzulli E, La Nasa G, Foà R, Breccia M.

Int J Cardiol. 2019 Aug 1;288:124-127. doi: 10.1016/j.ijcard.2019.04.051. Epub 2019 Apr 17.

PMID:
31029498
10.

Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis.

Pugliese N, Giordano C, Nappi D, Luciano L, Cerchione C, Annunziata M, Casale B, Crisà E, Villa MR, Pezzullo L, Iovine M, Picardi M, Grimaldi F, Pane F, Martinelli V.

Cancer Med. 2019 Jun;8(6):2802-2809. doi: 10.1002/cam4.2147. Epub 2019 Apr 17.

11.

Retrospective Analysis of Skin Toxicity in Patients under Anti-EGFR Tyrosine Kinase Inhibitors: Our Experience in Lung Cancer.

Annunziata MC, Ferrillo M, Cinelli E, Panariello L, Rocco D, Fabbrocini G.

Open Access Maced J Med Sci. 2019 Mar 27;7(6):973-977. doi: 10.3889/oamjms.2019.170. eCollection 2019 Mar 30.

12.

Adalimumab plus topical tacrolimus for the treatment of pyoderma gangrenosum: Report of a case.

Marasca C, Fontanella G, Annunziata MC, Marasca D, Fabbrocini G.

Int Wound J. 2019 Aug;16(4):1047-1048. doi: 10.1111/iwj.13123. Epub 2019 Apr 1. No abstract available.

PMID:
30938050
13.

Spatial and Temporal Profile of Glycine Betaine Accumulation in Plants Under Abiotic Stresses.

Annunziata MG, Ciarmiello LF, Woodrow P, Dell'Aversana E, Carillo P.

Front Plant Sci. 2019 Mar 7;10:230. doi: 10.3389/fpls.2019.00230. eCollection 2019. Review.

14.

A novel treatment for retronychia: case series.

Vastarella M, Annunziata MC, Panariello L, Ferrillo M, Fabbrocini G.

J Dermatolog Treat. 2019 Jun 14:1-2. doi: 10.1080/09546634.2019.1592098. [Epub ahead of print] No abstract available.

PMID:
30892971
15.

Arterial occlusive events in chronic myeloid leukemia patients treated with ponatinib in the real-life practice are predicted by the Systematic Coronary Risk Evaluation (SCORE) chart.

Caocci G, Mulas O, Abruzzese E, Luciano L, Iurlo A, Attolico I, Castagnetti F, Galimberti S, Sgherza N, Bonifacio M, Annunziata M, Gozzini A, Orlandi EM, Stagno F, Binotto G, Pregno P, Fozza C, Trawinska MM, De Gregorio F, Cattaneo D, Albano F, Gugliotta G, Baratè C, Scaffidi L, Elena C, Pirillo F, Scalzulli E, La Nasa G, Foà R, Breccia M.

Hematol Oncol. 2019 Mar 20. doi: 10.1002/hon.2606. [Epub ahead of print]

PMID:
30892724
16.

Comment on "Interruption of oral clindamycin plus rifampicin therapy in patients with hidradenitis suppurativa: an observational study to assess prevalence and causes".

Marasca C, Masarà A, Annunziata MC, Fattore D, Fabbrocini G.

J Am Acad Dermatol. 2019 Mar 11. pii: S0190-9622(19)30365-2. doi: 10.1016/j.jaad.2019.02.066. [Epub ahead of print] No abstract available.

PMID:
30872151
17.

Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice.

Fava C, Rege-Cambrin G, Dogliotti I, Cerrano M, Berchialla P, Dragani M, Rosti G, Castagnetti F, Gugliotta G, Martino B, Gambacorti-Passerini C, Abruzzese E, Elena C, Pregno P, Gozzini A, Capodanno I, Bergamaschi M, Crugnola M, Bocchia M, Galimberti S, Rapezzi D, Iurlo A, Cattaneo D, Latagliata R, Breccia M, Cedrone M, Santoro M, Annunziata M, Levato L, Stagno F, Cavazzini F, Sgherza N, Giai V, Luciano L, Russo S, Musto P, Caocci G, Sorà F, Iuliano F, Lunghi F, Specchia G, Pane F, Ferrero D, Baccarani M, Saglio G.

Haematologica. 2019 Aug;104(8):1589-1596. doi: 10.3324/haematol.2018.205054. Epub 2019 Feb 28.

18.

Successful treatment of psoriasis induced by immune checkpoint inhibitors with apremilast.

Fattore D, Annunziata MC, Panariello L, Marasca C, Fabbrocini G.

Eur J Cancer. 2019 Mar;110:107-109. doi: 10.1016/j.ejca.2019.01.010. Epub 2019 Feb 18. No abstract available.

PMID:
30785013
19.

Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.

Singhal S, Stadanlick J, Annunziata MJ, Rao AS, Bhojnagarwala PS, O'Brien S, Moon EK, Cantu E, Danet-Desnoyers G, Ra HJ, Litzky L, Akimova T, Beier UH, Hancock WW, Albelda SM, Eruslanov EB.

Sci Transl Med. 2019 Feb 13;11(479). pii: eaat1500. doi: 10.1126/scitranslmed.aat1500.

PMID:
30760579
20.

The impact of cancer: An Italian descriptive study involving 500 long-term cancer survivors.

Muzzatti B, Gipponi K, Flaiban C, Cormio C, Carnaghi C, Tralongo P, Caruso M, Cavina R, Tirelli U, Annunziata MA.

Eur J Cancer Care (Engl). 2019 May;28(3):e13007. doi: 10.1111/ecc.13007. Epub 2019 Feb 10.

PMID:
30740807
21.

Prurigo nodularis and pembrolizumab: A therapeutic challenge.

Fattore D, Panariello L, Annunziata MC, Fabbrocini G.

Eur J Cancer. 2019 Mar;110:8-10. doi: 10.1016/j.ejca.2019.01.012. Epub 2019 Feb 5. No abstract available.

PMID:
30735833
22.

Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia.

Raspadori D, Pacelli P, Sicuranza A, Abruzzese E, Iurlo A, Cattaneo D, Gozzini A, Galimberti S, Baratè C, Pregno P, Nicolosi M, Sorà F, Annunziata M, Luciano L, Caocci G, Moretti S, Sgherza N, Fozza C, Russo S, Usala E, Liberati MA, Ciofini S, Trawinska MM, Gozzetti A, Bocchia M.

Cytometry B Clin Cytom. 2019 Jul;96(4):294-299. doi: 10.1002/cyto.b.21764. Epub 2019 Feb 3.

PMID:
30714299
23.

Response of the Circadian Clock and Diel Starch Turnover to One Day of Low Light or Low CO2.

Moraes TA, Mengin V, Annunziata MG, Encke B, Krohn N, Höhne M, Stitt M.

Plant Physiol. 2019 Apr;179(4):1457-1478. doi: 10.1104/pp.18.01418. Epub 2019 Jan 22.

24.

Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review.

Fabbrocini G, Cantelli M, Masarà A, Annunziata MC, Marasca C, Cacciapuoti S.

Int J Womens Dermatol. 2018 Jun 19;4(4):203-211. doi: 10.1016/j.ijwd.2018.05.001. eCollection 2018 Dec. Review.

25.

The perceived severity of a disease and the impact of the vocabulary used to convey information: using Rasch scaling in a simulated oncological scenario.

Burro R, Savardi U, Annunziata MA, De Paoli P, Bianchi I.

Patient Prefer Adherence. 2018 Dec 3;12:2553-2573. doi: 10.2147/PPA.S175957. eCollection 2018.

26.

Acitretin may improve symptoms and exudation in patients affected by elephantiasis nostras verrucosa: Report of a case.

Marasca C, Mascolo M, Ferrillo M, Masarà A, Annunziata MC, Iacobelli A, Fabbrocini G.

Int Wound J. 2019 Apr;16(2):579-581. doi: 10.1111/iwj.13050. Epub 2018 Dec 13. No abstract available.

PMID:
30549253
27.

A contribution to the validation of the Italian version of the Body Image Scale (BIS).

Annunziata MA, Muzzatti B, Bomben F, Flaiban C, Piccinin M, Solfrini V.

BMC Cancer. 2018 Dec 6;18(1):1222. doi: 10.1186/s12885-018-5143-6.

28.

A Dermatological Questionnaire for General Practitioners with a Focus on Hidradenitis Suppurativa.

Marasca C, Annunziata MC, Cacciapuoti S, Cantelli M, Martora F, Scotti S, Sparano L, Fabbrocini G.

Open Access Maced J Med Sci. 2018 Oct 3;6(10):1902-1905. doi: 10.3889/oamjms.2018.358. eCollection 2018 Oct 25.

29.

Long-term clinical safety of clindamycin and rifampicin combination for the treatment of hidradenitis suppurativa: a strategy to reduce side-effects, improving patients' compliance.

Marasca C, Masarà A, Annunziata MC, Bettoli V, Luciano MA, Fabbrocini G.

Br J Dermatol. 2019 Apr;180(4):949. doi: 10.1111/bjd.17423. Epub 2019 Jan 1. No abstract available.

PMID:
30430549
30.

Marjolin's ulcer in a paraplegic man: A further example of the immunocompromised district.

Marasca C, Annunziata MC, Cantelli M, Marasca D, Fabbrocini G.

Int Wound J. 2019 Apr;16(2):574-575. doi: 10.1111/iwj.13022. Epub 2018 Nov 4. No abstract available.

PMID:
30393957
31.

Chemotherapy-induced periungual pyogenic granuloma: epidemiology and recurrence rates in our experience.

Annunziata MC, Vastarella M, Marasca C, Panariello L, Donnarumma M, Fabbrocini G.

G Ital Dermatol Venereol. 2018 Oct 11. doi: 10.23736/S0392-0488.18.06128-X. [Epub ahead of print] No abstract available.

PMID:
30318883
32.

Combination of permethrin 5% cream with liquid cleanser containing Chlorhexidine, agents from Szechuan peppers, menthol and camphor in scabies treatment results in high levels of subject satisfaction, favorable tolerability and less pruritus.

Greco V, Fattore D, Annunziata MC, Fabbrocini G.

G Ital Dermatol Venereol. 2018 Oct 3. doi: 10.23736/S0392-0488.18.06079-0. [Epub ahead of print] No abstract available.

PMID:
30295443
33.

Insulin resistance, mTOR and hidradenitis suppurativa.

Marasca C, Balato A, Annunziata MC, Cacciapuoti S, Fabbrocini G.

J Eur Acad Dermatol Venereol. 2019 Mar;33(3):e106-e107. doi: 10.1111/jdv.15271. Epub 2018 Oct 24. No abstract available.

PMID:
30288789
34.

Homocysteine plasma levels in patients affected by hidradenitis suppurativa: an Italian experience.

Marasca C, Donnarumma M, Annunziata MC, Fabbrocini G.

Clin Exp Dermatol. 2019 Apr;44(3):e28-e29. doi: 10.1111/ced.13798. Epub 2018 Oct 2. No abstract available.

PMID:
30280409
35.

Bullous pemphigoid and nivolumab: Dermatologic management to support and continue oncologic therapy.

Panariello L, Fattore D, Annunziata MC, Piantedosi F, Gilli M, Fabbrocini G.

Eur J Cancer. 2018 Nov;103:284-286. doi: 10.1016/j.ejca.2018.08.022. Epub 2018 Sep 26. No abstract available.

PMID:
30268391
36.

An oral supplementation based on myo-inositol, folic acid and liposomal magnesium may act synergistically with antibiotic therapy and can improve metabolic profile in patients affected by Hidradenitis Suppurativa: our experience.

Donnarumma M, Marasca C, Palma M, Vastarella M, Annunziata MC, Fabbrocini G.

G Ital Dermatol Venereol. 2018 Sep 20. doi: 10.23736/S0392-0488.18.06012-1. [Epub ahead of print]

PMID:
30249083
37.

[Effectiveness of the Situation-Background-Assessment-Recommendation (SBAR) methodology in patient handovers between nurses, Italy].

Rea T, Simeone S, Annunziata M, Serio C, Esposito MR, Gargiulo G, Guillari A.

Ig Sanita Pubbl. 2018 May-Jun;74(3):279-293. Italian.

PMID:
30235468
38.

EMPACT Syndrome in a Patient Treated With Phenobarbital.

Panariello L, Annunziata MC, Fabbrocini G, Lo Presti M, Delfino M.

Dermatitis. 2018 Sep/Oct;29(5):286-288. doi: 10.1097/DER.0000000000000377. No abstract available.

PMID:
30179969
39.

The PROSIT Cohort of Infliximab Biosimilar in IBD: A Prolonged Follow-up on the Effectiveness and Safety Across Italy.

Armuzzi A, Fiorino G, Variola A, Manetti N, Fries W, Orlando A, Maconi G, Bossa F, Cappello M, Biancone L, Cantoro L, Costa F, D'Incà R, Lionetti P, Principi M, Castiglione F, Annunziata ML, Di Sabatino A, Di Girolamo M, Terpin MM, Cortelezzi CC, Saibeni S, Amato A, Ardizzone S, Guidi L, Danese S, Massella A, Ventra A, Rizzuto G, Massari A, Perri F, Annese V; PROSIT Investigators.

Inflamm Bowel Dis. 2019 Feb 21;25(3):568-579. doi: 10.1093/ibd/izy264.

PMID:
30137352
40.

Unconventional therapies for hidradenitis suppurativa.

Marasca C, Annunziata MC, Napolitano M, Fabbrocini G.

Expert Rev Clin Pharmacol. 2018 Sep;11(9):879-887. doi: 10.1080/17512433.2018.1509706. Epub 2018 Aug 23. Review.

PMID:
30136871
41.

Confocal microscopy can assess the efficacy of combined microneedling and skinbooster for striae rubrae.

Mazzella C, Cantelli M, Nappa P, Annunziata MC, Delfino M, Fabbrocini G.

J Cosmet Laser Ther. 2018 Aug 21:1-4. doi: 10.1080/14764172.2018.1511913. [Epub ahead of print]

PMID:
30130428
42.

Response of Arabidopsis primary metabolism and circadian clock to low night temperature in a natural light environment.

Annunziata MG, Apelt F, Carillo P, Krause U, Feil R, Koehl K, Lunn JE, Stitt M.

J Exp Bot. 2018 Sep 14;69(20):4881-4895. doi: 10.1093/jxb/ery276.

43.

Anti-TNF-α therapy modulates mTORC1 signalling in hidradenitis suppurativa.

Balato A, Caiazzo G, Annunziata MC, Marasca C, Scala E, Cacciapuoti S, Fabbrocini G.

J Eur Acad Dermatol Venereol. 2019 Jan;33(1):e43-e45. doi: 10.1111/jdv.15160. Epub 2018 Jul 30. No abstract available.

PMID:
29956847
44.

The Role of Autologous Platelet Concentrates in Alveolar Socket Preservation: A Systematic Review.

Annunziata M, Guida L, Nastri L, Piccirillo A, Sommese L, Napoli C.

Transfus Med Hemother. 2018 May;45(3):195-203. doi: 10.1159/000488061. Epub 2018 May 3. Review.

45.

Residual Peripheral Blood CD26+ Leukemic Stem Cells in Chronic Myeloid Leukemia Patients During TKI Therapy and During Treatment-Free Remission.

Bocchia M, Sicuranza A, Abruzzese E, Iurlo A, Sirianni S, Gozzini A, Galimberti S, Aprile L, Martino B, Pregno P, Sorà F, Alunni G, Fava C, Castagnetti F, Puccetti L, Breccia M, Cattaneo D, Defina M, Mulas O, Baratè C, Caocci G, Sica S, Gozzetti A, Luciano L, Crugnola M, Annunziata M, Tiribelli M, Pacelli P, Ferrigno I, Usala E, Sgherza N, Rosti G, Bosi A, Raspadori D.

Front Oncol. 2018 May 30;8:194. doi: 10.3389/fonc.2018.00194. eCollection 2018.

46.

The Long and the Short of It: GA 2-oxidaseA9 Regulates Plant Height in Wheat.

Annunziata MG.

Plant Physiol. 2018 May;177(1):3-4. doi: 10.1104/pp.18.00235. No abstract available.

47.

Hyperbaric oxygen therapy (HBOT) can improve the effectiveness of adalimumab in Hidradenitis Suppurativa: report of a case.

Marasca C, Vivona G, Annunziata MC, Cacciapuoti S, Capasso E, Ciotola A, Russo G, Fabbrocini G.

G Ital Dermatol Venereol. 2018 Apr 19. doi: 10.23736/S0392-0488.18.05913-8. [Epub ahead of print] No abstract available.

PMID:
29683280
48.

Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.

Caocci G, Mulas O, Annunziata M, Luciano L, Bonifacio M, Orlandi EM, Pregno P, Galimberti S, Russo Rossi A, Abruzzese E, Iurlo A, Martino B, Sgherza N, Binotto G, Castagnetti F, Gozzini A, Fozza C, Bocchia M, Sicuranza A, Stagno F, Efficace F, Usala E, De Gregorio F, Scaffidi L, Elena C, Pirillo F, Baratè C, Trawinska MM, Cattaneo D, Labate C, Gugliotta G, Molica M, Specchia G, La Nasa G, Foà R, Breccia M.

Am J Hematol. 2018 Jul;93(7):E159-E161. doi: 10.1002/ajh.25102. Epub 2018 Apr 28. No abstract available.

49.

The effects of presenting oncologic information in terms of opposites in a medical context.

Burro R, Savardi U, Annunziata MA, De Paoli P, Bianchi I.

Patient Prefer Adherence. 2018 Mar 27;12:443-459. doi: 10.2147/PPA.S147091. eCollection 2018.

50.

A misdiagnosed case of furuncular myiasis in an Italian traveler returning from Kenya.

Marasca C, Annunziata MC, Donnarumma M, Russo G, Fabbrocini G.

G Ital Dermatol Venereol. 2018 Apr;153(2):288-289. doi: 10.23736/S0392-0488.16.05510-3. No abstract available.

PMID:
29564879

Supplemental Content

Loading ...
Support Center